Swine Influenza A Vaccines and Pandemic H1N1 Virus Cross-Reactivity
Author Information
Author(s): Dürrwald Ralf, Krumbholz Andi, Baumgarte Sigrid, Schlegel Michael, Vahlenkamp Thomas W., Selbitz Hans-Joachim, Wutzler Peter, Zell Roland
Primary Institution: IDT Biologika GmbH, Dessau Rosslau, Germany
Hypothesis
Do authorized swine influenza vaccine strains cross-react with the pandemic (H1N1) 2009 virus?
Conclusion
The study found that swine influenza vaccines can induce neutralizing antibodies against the pandemic (H1N1) 2009 virus, but the efficacy varies among different vaccine formulations.
Supporting Evidence
- Neutralizing activity was detected between the pandemic (H1N1) 2009 virus and European avH1N1 vaccine strains.
- High titers of neutralizing antibodies were induced by bivalent vaccines against avH1N1 and huH3N2 viruses.
- Cross-reactivity was confirmed through hemagglutination inhibition assays.
Takeaway
Scientists tested pig blood to see if vaccines could protect against a new flu virus, and they found that some vaccines worked better than others.
Methodology
The study used neutralization tests and hemagglutination inhibition assays on pig serum samples to assess cross-reactivity.
Limitations
The study may not fully represent all vaccine strains and their effectiveness across different populations of pigs.
Participant Demographics
Pigs from 195 German herds were included in the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website